ClinicalTrials.gov
ClinicalTrials.gov Menu

Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00463073
Recruitment Status : Completed
First Posted : April 20, 2007
Last Update Posted : December 11, 2008
Sponsor:
Collaborators:
Aalborg Universitetshospital
Odense University Hospital
Information provided by:
Rigshospitalet, Denmark

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2008
  Actual Study Completion Date : December 2008